CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
CTIC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.00%24.2714.1%$215.51m
SHPGShire PLC Sponsored ADR
1.01%163.490.4%$148.14m
JAZZJazz Pharmaceuticals Plc
0.00%178.502.2%$132.60m
SAGESAGE Therapeutics, Inc.
0.00%153.469.6%$122.44m
ENDPEndo International Plc
0.00%9.488.9%$88.71m
PRGOPerrigo Co. Plc
0.15%75.766.7%$88.07m
ICPTIntercept Pharmaceuticals, Inc.
0.00%85.6721.8%$66.06m
MNKMallinckrodt Plc
0.00%19.2621.1%$57.13m
PTLAPortola Pharmaceuticals, Inc.
0.00%43.737.7%$53.35m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.06%151.347.6%$52.65m
SUPNSupernus Pharmaceuticals, Inc.
0.00%57.056.3%$41.50m
HZNPHorizon Pharma plc
0.00%17.677.5%$38.10m
UTHRUnited Therapeutics Corporation
0.00%116.4714.4%$36.89m
PBHPrestige Brands Holdings, Inc.
0.00%38.133.8%$29.30m
MDCOMedicines Company
0.00%36.2821.8%$28.34m

Company Profile

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.